Assay for Assessing Mucin Binding to Bacteria and Bacterial Proteins

Lubov S Grigoryeva1, Saima Rehman2, Richard C White1

  • 1Department of Microbiology and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Bio-Protocol
|April 2, 2021
PubMed

Insights

Legionella pneumophila uses ChiA, a novel mucinase, to bind host mucins, aiding virulence. This study developed a flow cytometry method to measure bacterial and protein binding to mucins.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Bacterial Pathogenesis

Background:

  • Legionella pneumophila causes Legionnaires' disease by secreting virulence factors.
  • The ChiA protein is a T2SS effector with chitinase and mucinase activity.
  • Mucins are key components of host mucus barriers, crucial in lung infections.

Purpose of the Study:

  • To investigate the role of ChiA as a mucinase in L. pneumophila virulence.
  • To develop and validate a novel flow cytometry-based method for measuring bacterial and protein binding to mucins.
  • To assess the binding of L. pneumophila and purified ChiA to porcine stomach mucins.

Main Methods:

  • Green fluorescent protein (GFP)-labeled L. pneumophila strains (wild-type and chiA mutant) were incubated with porcine stomach mucins (Type II and Type III).
  • Mucins were labeled with TexasRed-tagged wheat germ agglutinin (WGA), and bacterial binding was analyzed by flow cytometry.
  • Binding of purified ChiA protein to mucins was also assessed using the same labeling and flow cytometry techniques.

Main Results:

  • The study successfully measured the binding of L. pneumophila to mucins using WGA and flow cytometry.
  • The presence of endogenous ChiA influenced bacterial binding to mucins.
  • Purified ChiA demonstrated direct binding to Type II and Type III porcine stomach mucins.

Conclusions:

  • ChiA's mucinase activity is a significant factor in L. pneumophila's interaction with host mucins.
  • The developed flow cytometry protocol provides a robust method for quantifying bacterial and protein-mucin interactions.
  • This research offers new insights into L. pneumophila pathogenesis and potential therapeutic targets.

Related Concept Videos